Credentialing Service forDSCSA Compliance
Spherity’s compact app to authenticate direct and indirect Authorized Trading Partners in real-time

CARO's Ecosystem
Minimize the complexity of regulatory requirements now
Don't get caught out by the 2023 deadline!
Solve the challenge of DSCSA Authorized Trading Partner (ATP) authentication. Run automated verifications with ease.

Easily plug into your existing processes
Go through a one-time onboarding process. Start directly without technical integration.
“Using the Spherity Credentialing Service in combination with SAP’s VRS, we have an electronic mechanism in place to verify each trading partner. There was no technical integration required to get started. All I had to do was to sign up with Spherity and tell my VRS that I want to use credentialing. I encourage all trading partners under DSCSA to add credentialing to their roadmap for 2023.”

Trading Partners in the pharmaceutical supply chain
Who is affected by the U.S. Drug Supply Chain Security Act (DSCSA)?
Manufacturer
Accepts or transfers direct product ownership. Must have valid registration.
Wholesale Distributor
Accepts or transfers direct product ownership. Must hold valid license.
Dispenser
Accepts or transfers direct product ownership. Must hold valid license.
Repackager
Accepts or transfers direct product ownership. Must have valid registration.
Third-Party Logistics Provider
Accepts or transfers direct product possession. Must hold valid license.
DSCSA Challenge
CARO is helping you close the compliance gap
The DSCSA requires new enhancements to pharmaceutical supply chain security by fall 2023.
Having instant assurance that you only interact with trusted and authorized trading partners is a huge challenge.
Challenge accepted
Using CARO you can:
- be sure that the counterparty is who they say they are;
- facilitate automated mutual Authorized Trading Partners checks in direct and indirect interactions;
- interact with counterparties using other OCI-conformant service providers;
- rely on secure messaging.
When using VRS initially, we utilized GLNs to identify a trading partner. We discovered GLNs that were not active or not associated with the requesting entity. GLNs also do not inform about authorized status. Additionally, we had no proof that the provided GLN actually came from the trading partner. This was a compliance gap we had to close.
Dave Mason
Supply Chain Compliance and Serialization Lead, Novartis
From our blog
Looking for a longer read? Enjoy our updates and informative articles.


Supporting you on your road to compliance
Solve the challenge of ATP authentication today and continue on your road to full DSCSA compliance by fall 2023.
Request a free trial